Paradigm Asset Management CO LLC Exact Sciences Corp Transaction History

Paradigm Asset Management CO LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$35.61 - $76.23 $42,732 - $91,476	-1,200 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$72.5 - $100.68 $14,500 - $20,136	-200 Reduced 14.29%	1,200 $93,000
Q3 2021 Nov 12, 2021	SELL	$90.24 - $124.05 $9,024 - $12,405	-100 Reduced 6.67%	1,400 $133,000
Q2 2021 Jul 30, 2021	SELL	$93.66 - $139.27 $18,732 - $27,854	-200 Reduced 11.76%	1,500 $186,000
Q1 2021 May 11, 2021	SELL	$116.57 - $155.01 $23,314 - $31,002	-200 Reduced 10.53%	1,700 $224,000
Q4 2020 Feb 12, 2021	BUY	$99.61 - $142.12 $189,259 - $270,028	1,900 New	1,900 $251,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.3B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Paradigm Asset Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Paradigm Asset Management CO LLC with notifications on news.